Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,499 | 2,397 | 3,941 | 2,198 | 2,667 |
| Gross Profit | 1,499 | 2,397 | 3,941 | 2,198 | 2,667 |
| Operating Expenses | 26,838 | 28,677 | 32,394 | 31,598 | 50,245 |
| Operating Income | -25,339 | -26,280 | -28,453 | -29,400 | -47,578 |
| Other Income | 1,057 | 1,195 | 1,415 | 1,852 | -6,520 |
| Pre-tax Income | -24,282 | -25,085 | -27,038 | -27,548 | -54,098 |
| Net Income Continuous | -24,282 | -25,085 | -26,488 | -27,548 | -54,098 |
| Net Income | $-24,282 | $-25,085 | $-26,488 | $-27,548 | $-54,098 |
| EPS Basic Total Ops | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 |
| EPS Basic Continuous Ops | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 |
| EPS Diluted Total Ops | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 |
| EPS Diluted Continuous Ops | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.26 | -0.28 | -0.30 | -0.35 |
| EBITDA(a) | $-24,758 | $-25,900 | $-27,931 | $-29,004 | $-46,704 |